Close Menu
Truth Republican
  • Home
  • News
  • Politics
  • Business
  • Guns & Gear
  • Healthy Tips
  • Prepping & Survival
  • Videos
Facebook X (Twitter) Instagram
Truth Republican
  • Home
  • News
  • Politics
  • Business
  • Guns & Gear
  • Healthy Tips
  • Prepping & Survival
  • Videos
Newsletter
Truth Republican
You are at:Home»Healthy Tips»Could GLP-1 weight-loss medications like Ozempic become the ‘everything drug’?
Healthy Tips

Could GLP-1 weight-loss medications like Ozempic become the ‘everything drug’?

Buddy DoyleBy Buddy DoyleSeptember 2, 2025No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp
Could GLP-1 weight-loss medications like Ozempic become the ‘everything drug’?
Share
Facebook Twitter LinkedIn Pinterest Email

NEWYou can now listen to Fox News articles!

GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and obesity.

But in recent months, studies have shown that these popular medications can have numerous other health benefits.

Some have even claimed that GLP-1s could eventually become the new “everything drug.”

MEDITERRANEAN DIET PAIRED WITH OTHER LIFESTYLE CHANGES SLASHES DIABETES RISK

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a “weight-inclusive” healthcare company based in Boston, said she would caution against labeling any medication as an “everything drug,” but agrees that GLP-1s show promise.

“GLP-1s are currently approved for treating obesity, type 2 diabetes, secondary prevention of cardiovascular disease, metabolic associated fatty liver disease, chronic kidney disease in patients with diabetes and sleep apnea,” she told Fox News Digital. 

“Further research is necessary to determine their efficacy in treating other chronic conditions.”

However, the drugs have shown “notable promise” in areas such as addiction treatment and the improvement of neurological conditions like Alzheimer’s, Fitch said.

DNA TEST REVEALS WHICH CHILDREN ARE AT HIGHER RISK OF OBESITY IN ADULTHOOD

“They lower blood pressure, lower cholesterol and decrease visceral adiposity,” she said. “They also significantly improve patients’ quality of life. They have many clinical indications today and many more to come.”

Top benefits of GLP-1s

Fitch listed the following primary benefits of GLP-1 medications.

  • Facilitating effective fat loss and maintenance
  • Controlling blood sugar and preventing diabetes in patients at risk
  • Lowering blood pressure
  • Improving lipids (achieving a healthy blood lipid profile)
  • Reducing risk of heart disease and kidney disease

“These are not amenities. They are the holy grail of modern medicine.”

Dr. Brett Osborn, a Florida neurosurgeon and longevity expert, believes that GLP-1s are “here to stay.”

“These medications don’t just treat obesity — they’re already showing promise in everything from cardiovascular disease to neurodegenerative disease to addiction,” he told Fox News Digital. 

“I’ve said it before, and I’ll say it again: These are not amenities. They are the holy grail of modern medicine.”

Potential risks and drawbacks

The most common side effects of GLP-1 medications are gastrointestinal-related.

Those include nausea, vomiting, diarrhea, constipation and bloating, especially during the initial dose escalation period, according to Fitch. 

woman injecting weight loss drug in stomach

“These symptoms often improve over time, but can be limiting for some patients,” she said. 

Other more serious, though rare, risks include pancreatitis, gallbladder disease and potential kidney injury — particularly if severe dehydration occurs due to vomiting, the expert cautioned.

“Not everyone tolerates them well, and we don’t have a complete handle yet on long-term side effects.”

Dr. Marc Siegel, Fox News senior medical analyst, has previously warned of GLP-1s’ side effects.

“Not everyone tolerates them well, and we don’t have a complete handle yet on long-term side effects,” he told Fox News Digital at the time.

“I certainly think they are useful — and can think of many situations where they decrease risks of heart disease, stroke, diabetes and cancer as well as the need for bariatric surgery — but they are surely not one-size-fits-all and are mostly not first-line therapy.”

Are all GLP-1s created equal?

Not all GLP-1 receptor agonists are the same, Fitch cautioned. 

“While they all act on the same basic pathway, their efficacy, side effect profiles and cardiovascular benefits can vary significantly,” she told Fox News Digital. 

Close-up of Ozempic pens and person injecting needle in background

Semaglutide, such as Ozempic and Wegovy, is currently considered the most potent GLP-1 for both weight loss and glycemic control, Fitch said, with evidence for cardiovascular benefit in people with type 2 diabetes and obesity. 

Semaglutide was also just approved as a treatment for MASH (Metabolic dysfunction–Associated SteatoHepatitis, a serious type of fatty liver disease). 

“Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist and has shown even greater weight loss in trials with a similar side effect profile,” Fitch said.

“Tirzepatide is approved for sleep apnea and is undergoing clinical trials for other indications.”

Mounjaro

Based on his own clinical experience, Osborn reiterated that in many cases, tirzepatide is a “superior agent.”

“It’s a dual incretin, meaning it targets two biochemical pathways,” he told Fox News Digital. “Not surprisingly, therefore, for patients who plateau on Wegovy, Zepbound often jump-starts weight loss.”

What to know before starting a GLP-1

GLP-1s are not a “magic bullet,” Fitch pointed out, noting that diet, exercise, sleep and behavioral changes are still essential to reaping the full benefits.

“Before taking GLP-1s, people should also know that side effects are common, and consistent clinical care and oversight is required to ensure safety and efficacy,” she advised. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“It is not something that people should just access via a form on the internet and treat themselves without good, comprehensive, longitudinal care.”

For chronic conditions like obesity or type 2 diabetes, Fitch recommends long-term or even indefinite use as the best approach. 

woman prepares smoothie with healthy foods

“Lowering the dose may become a viable maintenance strategy once a healthy weight is reached, though this approach is still under study,” she said. 

“Patients should consult their doctor to determine what course of action is best according to their specific needs.”

For more Health articles, visit www.foxnews.com/health

Anyone who is interested in starting a GLP-1 medication should consult with a doctor to discuss potential benefits and risks.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleTrump demands definitive answer amid ongoing debate over COVID-19 vaccines
Next Article Cracker Barrel hits back at ‘self interested’ Steak ‘n Shake CEO’s ‘poor leadership’ after online attacks

Related Articles

7 common fitness mistakes older adults make and how to avoid them for better workouts

7 common fitness mistakes older adults make and how to avoid them for better workouts

September 27, 2025
Common vitamin shown to slash skin cancer risk in some groups, study suggests

Common vitamin shown to slash skin cancer risk in some groups, study suggests

September 26, 2025
Autism symptoms in adults and new virus surge, plus GLP-1 benefits

Autism symptoms in adults and new virus surge, plus GLP-1 benefits

September 26, 2025
Best time to get the flu vaccine this fall as influenza season approaches

Best time to get the flu vaccine this fall as influenza season approaches

September 26, 2025
Blinded Army veteran who survived attack turns trauma into mission to help others

Blinded Army veteran who survived attack turns trauma into mission to help others

September 26, 2025
No more injections? New pill could replace Ozempic and Wegovy for weight loss

No more injections? New pill could replace Ozempic and Wegovy for weight loss

September 25, 2025
Weight-loss doctor shares how GLP-1s could rewire body against disease

Weight-loss doctor shares how GLP-1s could rewire body against disease

September 25, 2025
Dangerous spike in superbug infections surges across US as experts share cautions

Dangerous spike in superbug infections surges across US as experts share cautions

September 24, 2025
Girl shot in head during Minneapolis church massacre making ‘miraculous’ recovery

Girl shot in head during Minneapolis church massacre making ‘miraculous’ recovery

September 24, 2025
Don't Miss
Ciattarelli unloads on Mikie Sherrill in NJ town hall, citing immigration and Naval Academy: ‘Not a centrist’

Ciattarelli unloads on Mikie Sherrill in NJ town hall, citing immigration and Naval Academy: ‘Not a centrist’

These are the top global and US airlines based on new rankings: ‘Like flying private’

These are the top global and US airlines based on new rankings: ‘Like flying private’

TOP 5 MOST POWERFUL CROSSBOWS 2022

TOP 5 MOST POWERFUL CROSSBOWS 2022

Bondi declares ‘new era of political violence’ as federal agents deploy to ICE facilities nationwide

Bondi declares ‘new era of political violence’ as federal agents deploy to ICE facilities nationwide

Latest News
Michigan high school football player injured in vicious body slam returns to field in wheelchair

Michigan high school football player injured in vicious body slam returns to field in wheelchair

September 27, 2025
House Republican says teen son’s school promotes ‘non-monosexual identities’ in AM announcements, urges action

House Republican says teen son’s school promotes ‘non-monosexual identities’ in AM announcements, urges action

September 27, 2025
Trump vows ‘full force’ as he plans to send troops to Portland amid anti-ICE protests

Trump vows ‘full force’ as he plans to send troops to Portland amid anti-ICE protests

September 27, 2025
Joseph Naso, ‘Alphabet Killer,’ paid twisted homage to executed ‘Red Light Bandit’: investigator

Joseph Naso, ‘Alphabet Killer,’ paid twisted homage to executed ‘Red Light Bandit’: investigator

September 27, 2025
Russia Says A “False Flag” Provocation By Kiev Could Result In WW3

Russia Says A “False Flag” Provocation By Kiev Could Result In WW3

September 27, 2025
Copyright © 2025. Truth Republican. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Contact

Type above and press Enter to search. Press Esc to cancel.